乌比基特异性蛋白酶10:瘤免疫逃脱的新目标
Jingjing Huang1, Ning Li2, Jiangang Sun3
1Department of General Surgery, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Cancer control : journal of the Moffitt Cancer Center
|February 19, 2026
概括
乌比基特异蛋白酶10 (USP10) 稳定免疫检查点,促进瘤免疫逃生. 针对USP10可能通过调节瘤免疫微环境来增强癌症疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 瘤免疫逃脱在癌症治疗中是一个重大挑战.
- 乌比基特异蛋白酶10 (USP10) 是一种参与瘤发育的二维基化酶.
- USP10在瘤免疫逃生中的作用是一个新兴的研究领域.
研究的目的:
- 审查USP10.0的结构和功能特性.
- 详细介绍USP10在瘤发育和免疫逃生中的生物功能.
- 提供关于USP10在调节免疫检查点和瘤免疫微环境中的作用的见解.
主要方法:
- 文献综述侧重于USP10在癌症中的功能.
- 分析了USP10在脱氧化过程中的参与.
- 检查USP10对免疫检查点和细胞免疫的影响.
主要成果:
- USP10稳定了关键的免疫检查点,从而降低了瘤细胞的免疫性.
- 通过影响瘤微环境,USP10积极促进瘤免疫逃生.
- USP10 影响瘤微环境中的免疫细胞的功能.
结论:
- USP10在促进瘤免疫逃生方面发挥着至关重要的作用.
- 调节USP10表达提供了一个潜在的策略,以增强现有的癌症疗法.
- 了解USP10机制对于开发新型抗癌治疗至关重要.
相关概念视频
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.